Does Rallies show 13F holders for NKTX?

Yes. Rallies tracks hedge fund and 13F ownership data for NKTX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NKTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NKTX. It does not provide personalized investment advice.

NKTX (Nkarta, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Nkarta, Inc. Common Stock (NKTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NKTX trades at $2.80 with a market cap of $191.74M and a P/E ratio of -1.97. NKTX moved +4.10% today. Year to date, NKTX is +47.37%; over the trailing twelve months it is +55.56%. Its 52-week range spans $1.31 to $4.76. Analyst consensus is strong buy with an average price target of $12.50. Rallies surfaces NKTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NKTX stock?

Hedge funds tracked by Rallies that own NKTX include Orbimed Advisors and Panagora Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nkarta, Inc. Common Stock.

NKTX Key Metrics

Key financial metrics for NKTX
Metric	Value
Price	$2.80
Market Cap	$191.74M
P/E Ratio	-1.97
EPS	$-1.41
Dividend Yield	0.00%
52-Week High	$4.76
52-Week Low	$1.31
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-104.08M
Gross Margin	0.00%

Top Hedge Funds Holding NKTX

Orbimed Advisors holds 821.40K shares of NKTX, changed +0.00% as of Mar 31, 2025.
Panagora Asset holds 284.21K shares of NKTX, changed +0.00% as of Mar 31, 2026.

Latest NKTX News

Nkarta Extends Cash Runway to 2029 with $266.7M, Expands Outpatient Dosing — May 12, 2026
Nkarta Advances NKX019 to 12 Billion-Cell Cycle, Secures $295M Runway — Mar 25, 2026

Recent NKTX Insider Trades

HASTINGS PAUL J sold 26.05K (~$53.92K) on Jan 15, 2026.
Mahmood Nadir sold 5.65K (~$11.69K) on Jan 15, 2026.
HASTINGS PAUL J sold 1.79K (~$3.20K) on Jun 18, 2025.

NKTX Analyst Consensus

5 analysts cover NKTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.50.

Common questions about NKTX

Who owns NKTX stock?: Hedge funds tracked by Rallies that own NKTX include Orbimed Advisors and Panagora Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nkarta, Inc. Common Stock.
Does Rallies show 13F holders for NKTX?: Yes. Rallies tracks hedge fund and 13F ownership data for NKTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NKTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NKTX. It does not provide personalized investment advice.